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Introduction
Pituitary adenomas are variable in growth rate, potential 
of invasion and recurrence.  Some tumors grow fast; others 
remain in a dormant stage for a long time.  The recurrence 
rate is also difficult to predict, the pituitary adenomas that 
initially reduced the proliferation rate acquire a fast prolif-
eration rhythm and produce aggressive relapses.  The ability 
to predict the proliferative potential of pituitary adenomas 
could have major implications for the clinical management 
of these tumors.  Scientists have focused on identifying the 
predictive behaviour factors of pituitary adenomas. Ki67 
proliferative index has been shown to be a useful tool in the 
measurement of tissue proliferation and for this reason, has 
been extensively studied.
Material and methods
Eighty two cases of pituitary adenomas were studied.  The 
classification of human pituitary adenomas has been pro-
foundly assisted by immunohistochemistry.  Ki-67 antibody 
was used to assess the proliferative index of pituitary adeno-
mas. Ki67 proliferation index was performed using Nikon 
Eclipse E600 microscope at 400X magnification assisted by 
a specialized cell counting computer program (NSI).  The 
highest immunoreactivity areas were evaluated, an average 
of 1000 cells per case (about 3 microscopic fields taken as 
multimedia images) having been studied. 
Results
Ki67 proliferation index in the pituitary adenomas was 
noted as being increased in cases with recurrences.  There 
are no precise data on the pituitary hormones involve-
ment in determining either the proliferation rate of pitui-
tary adenomas or the growth factors.  For this reason, the 
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Abstract
Background: This article describes the growth rate of pituitary adenomas, their invasion and potential recurrence. Some of them grow rapidly while 
others remain in a dormant condition for a long time. The recurrence rate is also very hard to forecast. The pituitary adenomas that initially reduced 
their proliferation rate now acquire a rapid one, producing aggressive recurrences.
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Results: Acidophil type adenomas or acidophil cells areas within mixed pituitary adenomas had the highest proliferation rate.  Chromophobe pituitary 
adenomas were Ki67 negative in 90%, as well as the ones that presented the basophilic cells. The pituitary adenomas with a trabecular growth pattern 
had the lowest rate of proliferation, in about 50% of the cases being zero.  The heterogeneity expression of growth factors and corresponding receptors 
is dependent on hormonal profile of pituitary adenomas.
Conclusion: The pituitary adenomas proliferation rate depends on the type of secreted hormone as well as on the hormonal associations met in some 
cases of pituitary adenomas. 
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aim of the present study was to identify the potential role 
of pituitary hormones and growth factors, GFAP and S100 
protein in influencing the pituitary adenomas proliferation 
rate.  Proliferating pituitary adenomas represent 73.33% of 
all cases included in the study. Ki-67 expression was nuclear 
restricted the reaction intensity being variable, in most cases 
moderate and intense.  The proliferation rate was extremely 
heterogeneous within this group, ranging between 4/1000 
and 49/1000 (Fig. 1 a, b).
The highest proliferation rate was recorded in the acido-
phil type adenomas or acidophil cells areas within mixed pi-
tuitary adenomas.  Pituitary adenomas of the chromophobe 
type were Ki67negative in 90%, like basophilc cell adenomas.
According to the growth pattern, papillary type pituitary 
adenomas were proliferative, the proliferation rate in most 
cases being greater than 20/1000.
Pituitary adenomas with trabecular growth pattern 
showed the lowest proliferation rate, in about 50% of cases 
it is zero.  Pituitary adenomas with compact growth pattern 
had an average index of proliferation, being located between 
the papillary and the trabecular types.  The proliferation in-
dex of compact pituitary adenomas is middle, being located 
between the papillary and trabecular types.
Afterwards, we analysed the pituitary adenoma prolif-
eration rate in respect of their hormonal status.  In 50% of 
plurihormonal pituitary adenomas there was no prolifera-
tion, the index being denoted by 0.  The remaining plurihor-
monal type adenomas had a high proliferation index, 83.33% 
of which ranges between 21-41/1000.
Pure pituitary adenomas, which immunohistochemi-
cally expressed only one hormonal type were proliferating 
at a rate of 59% of the cases, 41% were not proliferative.  Ap-
proximately 80% of GH-secreting pituitary adenomas were 
proliferating at a rate of proliferation medium ranges be-
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tween 13-24 / 1000.  About 80% of GH-secreting pituitary 
adenomas were proliferating at a medium proliferation rate 
that ranges between 13-24/1000.
The co-expression of LH – FSH denotes tumor cells pro-
liferation. All LH -FSH positive cases were proliferating, but 
at a relatively low proliferation rate, in 60% of cases within 
the limits of 6-12 / 1000.
Non-secreting pituitary adenomas were proliferating in 
an amount of 77.8%. 57.14% of the proliferating cases had an 
average rate of proliferation, between 11-20 / 1000.  In this 
study we identified other hormonal combinations, differ-
ent from those specified before.  Their number was reduced 
so that these particular types required a separate analysis. 
Thus, the PRL -ACTH hormonal combination was found 
in one case of papillary adenoma predominantly basophilic 
with acidophilic areas where the proliferation rate was very 
high, i.e. 30/1000.  Another isolated case of GH-TSH hor-
mone profile also presented a relatively high rate of prolifera-
tion of 20/1000.  However, in most hormonal profile associa-
tions in which one of the hormones had been LH, the tumor 
cell proliferation rate was 0.  In fact, it was the only hormone 
for which we obtained a statistically significant inverse cor-
relation with Ki67 proliferation index taken from the Table 
correlation shown in figure 2.
Discussion
In 2004, the World Health Organization included a new 
subtype – “atypical” adenoma in the classification of pitui-
tary adenomas.  This entity has the following characteristics: 
a tumor proliferation index (Ki67) greater than 3%, p53 over 
expression and increased mitotic rate [1].  This new variant 
of adenoma is actually an intermediate step between con-
ventional adenomas and pituitary carcinoma (tumor entity 
that represents less than 1% of primary pituitary tumors) [2]. 
In most published studies, the proliferative index Ki-67 is 
linked to the hormonal profile of adenomas, the size and the 
degree of invasion thereof as determined by high-resolution 
imaging.  There is no correlation between Ki67 and archi-
tectural pattern of adenomas or its tinctorial character at the 
cytoplasmic level.
In his study Pawlikowski et al. [3] demonstrated that 
polyhormonal pituitary adenomas show higher Ki67values 
than the monohormonal ones, in particular those which 
co-express ACTH. In a previous study, the same researcher 
evaluated another proliferation nuclear marker – PCNA and 
the same results were found [4].  The lowest values of pro-
liferation markers were recorded for non-secreting adeno-
mas in both previous studies. Our study has shown similar 
results; the proliferation marker is highest in polyhormonal 
adenomas and lower in the case of non-secreting adenomas. 
On the other hand, there are studies that have shown other 
types of adenomas to have a higher proliferative index, such 
Fig. 1.  Variability of proliferation of pituitary adenomas.  
Pituitary adenomas of low proliferation rate (a)  
and high proliferative rate (b).
Fig. 2.  The statistical analysis of correlation between Ki67 proliferation index and LH is shown.  
An inverse correlation between the expression of LH and proliferation rate is noted.
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as prolactinoma [5] or ACTH-secreting adenomas [2, 6]. 
Some studies suggest that prolactinoma with increased pro-
liferation index, besides the risk of recurrence, is pituitary 
carcinomas precursors [6].
The data given in literature indicate low levels of prolifer-
ation marker Ki 67 in both gonadotropic hormone-secreting 
adenomas, and non-secreting ones [1, 6, 7].
In addition to existing data, the present study has dem-
onstrated that polyhormonal adenomas including co-ex-
pression of LH present a low proliferation index.
Conclusions
1. The heterogeneity expression of growth factors and
corresponding receptors is dependent on hormonal profile 
of pituitary adenomas.
2. Secreting GH and PRL pituitary adenomas are the
most active in terms of synthesis and release of growth fac-
tors.
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